Cyclacel Pharmaceuticals, Inc. logo

Cyclacel Pharmaceuticals, Inc.

Translating cancer biology into medicines.

12 employees · est. 1996 · Dundee, United States

VS
Vicinitas Therapeutics logo

Vicinitas Therapeutics

Advancing a one-of-a-kind protein stabilization platform to develop novel therapeutics for cancer and genetic disorders.

4 employees · est. 2022 · South San Francisco, United...

Cyclacel Pharmaceuticals, Inc. is the older company (1996 vs 2022); Cyclacel Pharmaceuticals, Inc. is the larger of the two.

Side-by-Side Comparison

Cyclacel Pharmaceuticals, Inc. Vicinitas Therapeutics
Founded
1996 older 2022
Headquarters
Dundee, United States South San Francisco, United States
Employees
12 larger 4
Industry
Biotechnology, Health Care, Health and Wellness Biotechnology, Health and Wellness, Life Sciences
Funding Stage
Post Ipo Equity Series A
Total Funding
$157.54M $65.00M
Funding Rounds
13 1
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Pharmaceuticals, Biopharmaceutical, Cancer Treatment, Cell Cycle Control, Oral Therapies, Tumor Suppressor Biology, Cell Biology, Mitosis Mechanism, Mitotic Kinases, P53 Protein, Cancer Research, Drug Development, Sir David Lane, Professor David Glover, London Protein Stabilization, Cancer Therapeutics, Genetic Disorder Therapies, Targeted Protein Stabilizers, Deubiquitinase Targeting Chimeras, DUBTAC Platform, Undruggable Proteins, Proteomics, Tumor Suppressors, Academic-Industry Collaboration, Drug Discovery, Monogenic Diseases, Therapeutic Development, Novel Therapeutics
Website
cyclacel.com vicinitastx.com
Cyclacel Pharmaceuticals, Inc. logo

About Cyclacel Pharmaceuticals, Inc.

Cyclacel Limited, with its slogan "Translating cancer biology into medicines," is a pharmaceutical company based out of 46-48 E Smithfield, London, United Kingdom. Founded in 1996, the company operates within the Biotechnology, Health Care, and Pharmaceutical industries. Cyclacel Limited recently se...

Vicinitas Therapeutics logo

About Vicinitas Therapeutics

Vicinitas Therapeutics, established in 2022, is a promising biotechnology startup based in South San Francisco, California. Their tagline, "Advancing a one-of-a-kind protein stabilization platform to develop novel therapeutics for cancer and genetic disorders," encapsulates their innovative approach...

We will tell you when either one moves

BounceWatch watches Cyclacel Pharmaceuticals, Inc. and Vicinitas Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Cyclacel Pharmaceutica... and Vicinitas Therapeutics — by email.

Frequently Asked Questions

Cyclacel Pharmaceuticals, Inc. — Translating cancer biology into medicines.. Vicinitas Therapeutics — Advancing a one-of-a-kind protein stabilization platform to develop novel therapeutics for cancer and genetic disorders.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Cyclacel Pharmaceuticals, Inc. has raised $157.54M while Vicinitas Therapeutics has raised $65.00M.
Cyclacel Pharmaceuticals, Inc. and Vicinitas Therapeutics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Cyclacel Pharmaceuticals, Inc. with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Cyclacel Pharmaceuticals, Inc. on 11 Sep 2024, and Vicinitas Therapeutics on 28 Jan 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy